HKD 0.6
(0.0%)
Year | Gross Profit | Gross Profit Growth |
---|---|---|
2023 | 14.39 Million CNY | -27.61% |
2022 | 19.88 Million CNY | 112.31% |
2021 | 9.36 Million CNY | -48.53% |
2020 | 18.2 Million CNY | 163.26% |
2019 | 6.91 Million CNY | 0.0% |
Year | Gross Profit | Gross Profit Growth |
---|---|---|
2024 Q1 | 762 Thousand CNY | -64.44% |
2024 Q2 | 762 Thousand CNY | 0.0% |
2023 Q1 | 5.05 Million CNY | -39.87% |
2023 FY | 14.39 Million CNY | -27.61% |
2023 Q4 | 2.14 Million CNY | 0.0% |
2023 Q3 | 2.14 Million HKD | -57.61% |
2023 Q2 | 5.05 Million CNY | 0.0% |
2022 Q2 | 1.53 Million CNY | 0.0% |
2022 Q1 | 1.53 Million CNY | -36.63% |
2022 FY | 19.88 Million CNY | 112.31% |
2022 Q4 | 8.4 Million CNY | 0.0% |
2022 Q3 | 8.4 Million CNY | 447.43% |
2021 Q3 | 2.42 Million CNY | 36.03% |
2021 Q4 | 2.42 Million CNY | 0.0% |
2021 Q2 | 1.78 Million CNY | -34.92% |
2021 Q1 | 2.73 Million CNY | -22.47% |
2021 FY | 9.36 Million CNY | -48.53% |
2020 Q1 | 2.06 Million CNY | 0.0% |
2020 FY | 18.2 Million CNY | 163.26% |
2020 Q4 | 3.53 Million CNY | 0.0% |
2020 Q3 | 3.53 Million CNY | -61.07% |
2020 Q2 | 9.07 Million CNY | 338.9% |
2019 FY | 6.91 Million CNY | 0.0% |
Name | Gross Profit | Gross Profit Difference |
---|---|---|
Uni-Bio Science Group Limited | 392.81 Million HKD | 96.335% |
CK Life Sciences Int'l., (Holdings) Inc. | 947.7 Million HKD | 98.481% |